Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|67|2|794-796

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.67, Iss.2, 2018-02, pp. : 794-796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 7-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

John Wiley & Sons Inc

Access to resources Recommend Favorite

Will IL28B polymorphism remain relevant in the era of direct‐acting antiviral agents for hepatitis C virus?

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 373-381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 228-238

John Wiley & Sons Inc

Access to resources Recommend Favorite